Entries by Tanya Samazan

Pall Debuts Filtration Solutions for Biotech Research

As the number of biotech drugs in development grows exponentially, lab protein and cell purification workflows are facing increasing demand. Such workflows include clone selection, cell expansion studies and recombinant protein isolation prior to analysis. Suppliers of filtration and clarification consumables have responded by innovating to accelerate these workflows. Pall, one of the largest suppliers […]

NIH Lays Out Vision for Nutrition Research

The National Instituts of Health (NIH) has released the “2020–2030 Strategic Plan for NIH Nutrition Research,” developed by the NIH Nutritional Research Task Force. The report calls for research investments in Precision Nutrition. Unlike personalized nutrition or nutrigenomcis, Precision Nutrituion encompasses both internal and external contributions: diet, genetics, physical health, microbiome, metabolism, dietary habits, activity […]

A Continuous Flow of Investments in COVID-19 R&D

In the IBO blog’s fourth look at coronavirus-related R&D funding, the focus is on announcements made in May. Governments continue to make large commitments, with funding ultimately designated for universities, research institutes, the private sector, and infectious disease research organizations that will coordinate efforts to funnel money to all three sectors. These organizations include CEPI […]

A Steady Stream of New Funding for COVID-19 R&D

This is the third of IBO’s review of R&D investments related to COVID-19 (see March 27 and April 17). The outbreak has triggered a wide range of responses spanning immediate and long-term solutions. For R&D, spending priorities range from areas  such as new diagnostic approaches and vaccine development to basic research in fields such as […]

A Step Forward for Point-of-Care Testing: COVID-19 Tests Gain FDA EUA Approval

Marking another new step forward in more effective COVID-19 testing, as of April 2, the US FDA had approved three molecular point-of-care (POC) tests for COVID-19. The POC assays enable testing in patient care settings such as doctors’ offices and urgent care facilities. POC tests are one of the urgently needed solutions to address the […]

Funding Floodgates Open for COVID-19 R&D

Selected March 2020 COVID-19 Related R&D Funding Announcements Source Recipients Amount Details France National Research Agency and others €5 billion ($5 billion) The investment marks increase over 10 years to the country’s science budget. According to Reuters, 20% will go towards preparing for possible future epidemics. The funding encompasses €50 million ($54 million) in emergency […]

Pittcon 2020 Company Press Conferences

Marking the conference and exhibit’s 71st year, Pittcon 2020, organized by the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy was held in Chicago, Illinois from March 1 to March 5 (short courses began February 29). The conference is one of the largest conferences and exhibition for analytical chemists and other scientists. As usual, several […]

Pittcon 2020 and the Coronavirus Impact

The coronavirus outbreak has led to the cancellation or postponement of many major scientific conferences planned for this spring. One conference that did take place was Pittcon 2020 (Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy). Held February 29 through March 5 in Chicago, Illinois, Pittcon 2020 took place before new advisories were issued, enabling […]

IXRF: Putting X-ray Fluorescence Spectroscopy First

IXRF has carved a unique path for itself. Founded in 1993, the company is a dedicated provider of x-ray fluorescence (XRF) technology, specializing in small, affordable benchtop systems. But the company’s history lies in the use of XRF with scanning electron microscopy (SEM). IXRF will be exhibiting at this week’s Pittcon conference, one of the […]